Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)
Conditions: SR aGvHD; Acute-graft-versus-host Disease; Steroid Refractory Acute Graft Versus Host Disease; Graft-versus-host-disease; Graft Vs Host Disease; Alpha 1-Antitrypsin Deficiency; Alpha-1 Proteinase Inhibitor; Alpha-1 Protease Inhibitor Deficiency; Acute Graft-Ve rsus-Host Reaction Following Bone Marrow Transplant Intervention: Drug: Glassia Sponsors: Impatients N.V. trading as myTomorrows; Kamada, Ltd. Available - verified May 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alpha-1 Antitrypsin Deficiency | Bone Marrow Transplant | Stem Cell Therapy | Stem Cells | Transplants